Harness attend the 19th Annual Huntington's Disease Therapeutics Conference

Join us in Palm Springs as we take part in the 19th annual Huntington's Disease Therapeutics Conference organised by the CHDI Foundation from February 26th to 29th!

Our CEO, Jan Thirkettle, and SVP Programme Management & Operations, Madeleine Wakeling, are excited to attend the key event of the HD calendar to catch up with existing collaborators and meet potential new partners. Harness Therapeutic’s lead programme, based on physiological upregulation of FAN1, targets a mechanism that could lead to truly meaningful disease modification.

“We’re excited to be part of this community at a time when the field is advancing so rapidly in both research and therapeutic development and look forward to catching up on all the progress at the conference.”

See you in Palm Springs!

#huntingtonsdisease #conference2024 #innovation #collaboration #healthcareinnovation #palmsprings #networkingopportunities #biotechnology #chdi

Our vision

Building the leading platform for physiological upregulation of neurodegenerative disease targets to enable truly disease-modifying therapies.

Our approach

Deep expertise & unique capabilities in RNA biology & neurodegeneration

High value targets

Ready to scale

Learn more

Our programmes

Preventing the progression of Huntington’s Disease

Discover more

Our news

View all